145 related articles for article (PubMed ID: 12108885)
1. Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma.
Van Schoor J; Joos GF; Pauwels RA
Eur Respir J; 2002 Jun; 19(6):997-1002. PubMed ID: 12108885
[TBL] [Abstract][Full Text] [Related]
2. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
[TBL] [Abstract][Full Text] [Related]
3. Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma.
Hofstra WB; Neijens HJ; Duiverman EJ; Kouwenberg JM; Mulder PG; Kuethe MC; Sterk PJ
Pediatr Pulmonol; 2000 Jun; 29(6):415-23. PubMed ID: 10821721
[TBL] [Abstract][Full Text] [Related]
4. Changes in neurokinin A airway responsiveness with inhaled lysine-acetylsalicylate in asthma.
Crimi N; Polosa R; Prosperini G; Magrì S; Ciamarra I; Mistretta A
Eur Respir J; 1996 Jun; 9(6):1139-45. PubMed ID: 8804929
[TBL] [Abstract][Full Text] [Related]
5. Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness.
Langley SJ; Holden J; Derham A; Hedgeland P; Sharma RK; Woodcock A
Chest; 2002 Sep; 122(3):806-11. PubMed ID: 12226017
[TBL] [Abstract][Full Text] [Related]
6. Changes in neurokinin A (NKA) airway responsiveness with inhaled frusemide in asthma.
Crimi N; Prosperini G; Ciamarra I; Mastruzzo C; Magri S; Polosa R
Thorax; 1997 Sep; 52(9):775-9. PubMed ID: 9371207
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhaled steroids on methacholine-induced bronchoconstriction and gas trapping in mild asthma.
Corsico A; Pellegrino R; Zoia MC; Barbano L; Brusasco V; Cerveri I
Eur Respir J; 2000 Apr; 15(4):687-92. PubMed ID: 10780760
[TBL] [Abstract][Full Text] [Related]
8. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
9. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
Noonan MJ; Chervinsky P; Wolfe J; Liddle R; Kellerman DJ; Crescenzi KL
J Asthma; 1998; 35(2):153-64. PubMed ID: 9576141
[TBL] [Abstract][Full Text] [Related]
10. Airway responsiveness to adenosine after a single dose of fluticasone propionate discriminates asthma from COPD.
Spicuzza L; Scuderi V; Morjaria JB; Prosperini G; Arcidiacono G; Caruso M; Folisi C; Di Maria GU; Polosa R
Pulm Pharmacol Ther; 2014 Feb; 27(1):70-5. PubMed ID: 23688422
[TBL] [Abstract][Full Text] [Related]
11. Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma.
Kanniess F; Richter K; Böhme S; Jörres RA; Magnussen H
Eur Respir J; 2002 Oct; 20(4):853-8. PubMed ID: 12412675
[TBL] [Abstract][Full Text] [Related]
12. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma.
Ketchell RI; Jensen MW; Lumley P; Wright AM; Allenby MI; O'connor BJ
J Allergy Clin Immunol; 2002 Oct; 110(4):603-6. PubMed ID: 12373268
[TBL] [Abstract][Full Text] [Related]
13. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
Boulet LP; Turcotte H; Prince P; Lemière C; Olivenstein R; Laprise C; Larivée P; Bégin P; Laviolette M
Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221
[TBL] [Abstract][Full Text] [Related]
14. Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction.
Luijk B; Kempsford RD; Wright AM; Zanen P; Lammers JW
Eur Respir J; 2004 Apr; 23(4):559-64. PubMed ID: 15083754
[TBL] [Abstract][Full Text] [Related]
15. The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics.
Van Schoor J; Joos GF; Chasson BL; Brouard RJ; Pauwels RA
Eur Respir J; 1998 Jul; 12(1):17-23. PubMed ID: 9701408
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
Parameswaran K; Inman MD; Watson RM; Morris MM; Efthimiadis A; Ventresca PG; Lam R; O'Byrne PM; Hargreave FE
Can Respir J; 2000; 7(4):313-9. PubMed ID: 10980457
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
[TBL] [Abstract][Full Text] [Related]
19. Fifty microg b.i.d. of inhaled fluticasone propionate (FP) are effective in stable asthmatics previously treated with a higher dose of FP.
Giannini D; Di Franco A; Tonelli M; Bartoli ML; Carnevali S; Cianchetti S; Bacci E; Dente FL; Vagaggini B; Paggiaro PL
Respir Med; 2003 May; 97(5):463-7. PubMed ID: 12735661
[TBL] [Abstract][Full Text] [Related]
20. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma.
Currie GP; Stenback S; Lipworth BJ
Br J Clin Pharmacol; 2003 Jul; 56(1):11-7. PubMed ID: 12848770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
